Search

Your search keyword '"Schütz, Catharina"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Schütz, Catharina" Remove constraint Author: "Schütz, Catharina"
110 results on '"Schütz, Catharina"'

Search Results

2. A corpus of GA4GH phenopackets: Case-level phenotyping for genomic diagnostics and discovery

4. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study

6. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

8. The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human disease

10. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

11. Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome

12. A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.

13. A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

20. LUBAC Deficiencies

21. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

28. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency

30. Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study

34. Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome

35. Clinical, immunological features, treatments, and outcomes of autoimmune hemolytic anemia in patients with RAG deficiency

37. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator–dependent autoimmunity

38. Prospective Newborn Screening for SCID in Germany: A first analysis by the Pediatric Immunology Working Group (API)

39. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID

40. Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care

41. Langfristige Wirksamkeit und Sicherheit von Canakinumab bei Patienten mit TRAPS (Tumornekrose­faktor-Rezeptor­assoziiertes periodisches Syndrom) – Zwischenanalyse des RELIANCE-Registers

42. Behandlung und Outcomes neu diagnostizierter Patient:innen mit polyartikulärer juveniler idiopathischer Arthritis (pJIA) – erste Ergebnisse aus ProKind-Rheuma

43. Muskuloskelettaler Ultraschall bei juveniler Dermatomyositis – stratifiziertes Bewertungsvefahren

44. Impfsicherheit unter Canakinumab bei Patienten mit autoinflammatorischen periodischen Syndromen – Interimsanalyse des RELIANCE-Registers

45. Langzeitsicherheit und Wirksamkeit von Canakinumab bei Cryopyrin-assoziierten periodischen Syndromen (CAPS) – 36-Monats-Daten aus dem RELIANCE-Register

46. Clinical, Immunological Features, Treatments, and Outcomes of Autoimmune Hemolytic Anemia in Patients with RAG Deficiency

47. Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients with Activated PI3K Delta Syndrome (APDS) through December 2021

49. 'Ubi apis, ibi salus – wo Bienen sind, dort ist Gesundheit' – eine theoretische Annäherung an die Möglichkeiten tiergestützter Arbeit mit Honigbienen im integrativen Verfahren

Catalog

Books, media, physical & digital resources